- Previous Close
27.25 - Open
27.25 - Bid 27.00 x --
- Ask 27.50 x --
- Day's Range
27.25 - 27.25 - 52 Week Range
27.25 - 37.83 - Volume
1,800 - Avg. Volume
33 - Market Cap (intraday)
4.36B - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
12.11 - EPS (TTM)
2.25 - Earnings Date --
- Forward Dividend & Yield 1.37 (4.68%)
- Ex-Dividend Date Mar 19, 2025
- 1y Target Est
--
Nonthavej Hospital Public Company Limited operates as a hospital in Thailand. The company provides medical services for inpatients and outpatients, as well as emergency cases with 24-hour ambulance service. It operates specialized medical centers and clinics that offer services in the areas of laparoscope surgery, breast cancer, children and teens, neurology, dental, diabetes, diagnostic digital imaging, emergency, gastrointestinal system and liver, general medicine, gynecologic cancer treatment, gynecologic laparoscopic surgery and gynecologic cancer, gynecological, hemodialysis, ICU and CCU, minimally invasive surgery, nephrology, operations, orthopedics, pain clinic, physical medicine and rehabilitation, pregnancy, respiration, skin and cosmetic surgery, sleep lab, vascular, and wellness, as well as eye, ear, nose, and throat. In addition, the company provides health checkup, ambulatory, and ward facility services. Nonthavej Hospital Public Company Limited was founded in 1981 and is headquartered in Nonthaburi, Thailand.
www.nonthavej.co.th--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NTV-R.BK
View MorePerformance Overview: NTV-R.BK
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NTV-R.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NTV-R.BK
View MoreValuation Measures
Market Cap
4.36B
Enterprise Value
3.42B
Trailing P/E
13.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.89
Price/Book (mrq)
1.70
Enterprise Value/Revenue
1.38
Enterprise Value/EBITDA
5.52
Financial Highlights
Profitability and Income Statement
Profit Margin
14.43%
Return on Assets (ttm)
8.79%
Return on Equity (ttm)
13.37%
Revenue (ttm)
2.5B
Net Income Avi to Common (ttm)
360.74M
Diluted EPS (ttm)
2.25
Balance Sheet and Cash Flow
Total Cash (mrq)
935.04M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
274.55M